Kaplan-Meier analysis of OS for treatment-naïve and relapsed/refractory patients with CMML receiving tagraxofusp 12 μg/kg per day. NE, not estimable.
Figure 1.

Kaplan-Meier analysis of OS for treatment-naïve and relapsed/refractory patients with CMML receiving tagraxofusp 12 μg/kg per day. NE, not estimable.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal